| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e612ff5af01f3560088310b19f23e129
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ee66b348266854e19b6bcb50ee3ea8c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate |
2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68aaedfdebd35f8416c2ded735c5a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e690b49d9b67583ca4b7af4c1f9fe5 |
| publicationDate |
2020-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10808247-B2 |
| titleOfInvention |
Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach |
| abstract |
In one aspect, the disclosure provides methods for treating a neurodegenerative disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a nucleic acid molecule and a therapeutically effective amount of a small molecule that activates NF-κB p65 and increases expression of manganese superoxide dismutase (MnSOD/SOD2) and/or expression of a related protein or enzyme. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11584933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11396654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254940-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279934-B2 |
| priorityDate |
2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |